- 1. 125-Iodine
- [A radioactive isotope of iodine, a nonmetallic element of the halogen group. With a half-life of 60 days, iodine 125 occurs naturally and can be produced artificially. This agent has both therapeutic and diagnostic uses, particularly in thyroid disease. (NCI04) ( NCI )] (UMLS (NCI) C0796396) I-125;
I125 isotope;
Iodine 125;
Iodine I 125;
Iodine I-125;
IODINE,I-125;
IODINE,I-125 PREPARATION;
=Pharmacologic Substance; Indicator, Reagent, or Diagnostic Aid; Element, Ion, or Isotope =I;
Inactive Ingredient Preparations =IODINE,I-125 0.01 MIC | - 33. ion channel blocker
- [agent that selectively inhibits ion flux through its channel. ( CSP )] (UMLS (CSP) C0872051) =Chemical Viewed Functionally ;
=inhibitor/antagonist;
=[CV200] CALCIUM CHANNEL BLOCKERS |
- 2. 131-Iodine
- [A radioactive isotope of iodine with an atomic mass of 131, a half life of eight days, and potential antineoplastic activity. Selectively accumulating in the thyroid gland, iodine I 131 emits beta and gamma particles, thereby killing thyroid cells and decreasing thyroid hormone production. ( NCI )] (UMLS (NCI) C0303029) =Pharmacologic Substance; Indicator, Reagent, or Diagnostic Aid; Element, Ion, or Isotope
| - 34. ion channel in biomembrane
- [ ] (UMLS (CSP) C0598839) =Amino Acid, Peptide, or Protein; Biologically Active Substance
|
- 3. 5-Iodo-2-pyrimidinone-2'-deoxyribose
- [An oral prodrug of 5-iododeoxyuridine (IUdR), an iodinated analogue of deoxyuridine and radiosensitizing agent. 5-Iodo-2-pyrimidinone-2-deoxyribose (IPdR) is efficiently converted to IUdR by a hepatic aldehyde oxidase. This results in increased IUdR plasma levels compared to oral IPdR and increased toxicity profile compared to intravenous administered IUdR. IUdR is incorporated into DNA during the S-phase of the cell cycle, thereby sensitizing cells to ionizing radiation by increasing DNA strand breaks. ( NCI )] (UMLS (NCI) C0088688) =Nucleic Acid, Nucleoside, or Nucleotide; Pharmacologic Substance
| - 35. Ion Channel Protein
- [Ion Channel Proteins typically aggregate in membrane-associated complexes forming pores whose activities regulate the movement of ions through cellular membranes to affect cellular homeostatic conditions and/or signaling processes. (NCI) ( NCI )] (UMLS (NCI) C1334283) =Amino Acid, Peptide, or Protein; Biologically Active Substance
|
- 4. Iocetamic Acid
- (UMLS (NCI) C0650160) =Organic Chemical; Pharmacologic Substance ;
=Iodobenzenes;
[DX102] IONIC CONTRAST MEDIA =IOCETAMIC ACID 750 MG;
| - 36. Ion Channel Protein Gene
- [Ion Channel Protein Genes encode Ion Channel Proteins that typically aggregate in membrane-associated complexes forming pores whose activities regulate the movement of ions through cellular membranes to affect cellular homeostatic conditions and/or signaling processes. (NCI) ( NCI )] (UMLS (NCI) C1334284) =Gene or Genome ;
|
- 5. IODAMIDE
- [An ionic monomeric contrast medium. (From Martindale, The Extra Pharmacopoeia, 30th ed, p706) ( MSH )] (UMLS (NCI) C0021961) =Organic Chemical; Indicator, Reagent, or Diagnostic Aid ;
=Triiodobenzoic Acids;
=Iodamide Meglumine | - 37. ion cyclotron resonance spectrometry
- [mass spectrometry in which the mass distribution of orbiting ions within a magnetic field is detected by bringing ion frequencies sequentially into resonance with applied radio frequencies. ( CSP )] (UMLS (CSP) C0596799) =Laboratory Procedure =Mass Spec;
|
- 6. Iodamide Meglumine
- (UMLS (NCI) C0065884) =Organic Chemical; Indicator, Reagent, or Diagnostic Aid ;
=IODAMIDE;
[DX102] IONIC CONTRAST MEDIA =IODAMIDE MEGLUMINE 24 %;
IODAMIDE MEGLUMINE 65 % | - 38. ion exchange chromatography
- [separation technique in which the stationary phase consists of ion exchange resins; the resins contain loosely held small ions that easily exchange places with other small ions of like charge present in solutions washed over the resins. ( CSP )] (UMLS (CSP) C0008564) =Laboratory Procedure =chromatography;
|
- 7. Iodinated Contrast Dye
- [A contrast agent containing an iodine-based dye used in many diagnostic imaging examinations, including computed tomography, angiography, and myelography. ( NCI )] (UMLS (NCI) C0879373) =Indicator, Reagent, or Diagnostic Aid
| - 39. Ion selective electrode (ISE)
- [Electrochemical, Ion Selective Electrode ( HL7V3.0 )] (UMLS (HL7) C0201747) =Laboratory Procedure =ObservationMethod;
|
- 8. iodination
- [incorporation or addition of iodide in a compound. ( CSP )] (UMLS (CSP) C0542502) =Natural Phenomenon or Process ;
=halogenation;
| - 40. ion transport
- [movement of ions across cell membranes; can be active, passive or facilitated; ions may travel by themselves (uniport), or as a group of two or more ions in the same (symport) or opposite (antiport) directions. ( CSP )] (UMLS (CSP) C0162585) =Cell Function ;
=biological transport;
=ionophore |
- 9. Iodine Administration
- (UMLS (HL7) C1548871) =Health Care Activity =Consent Type;
| - 41. ionamine
- [ ] (UMLS (CSP) C0022016) =Organic Chemical; Pharmacologic Substance
|
- 10. IODINE HYPOTHYROIDISM
- (UMLS (ICD9CM) C0154159) =Disease or Syndrome
| - 42. Ione Band of Miwok Indians of California
- (UMLS (HL7) C1554328) =Population Group =NativeEntityContiguous;
|
- 11. Iodine I 125/Polifeprosan 20 With Carmustine Implant
- (UMLS (NCI) C0796642) =Therapeutic or Preventive Procedure
| - 43. ionic balance
- [ ] (UMLS (CSP) C0598358) =Organism Function ;
|
- 12. Iodine I 131 Monoclonal Antibody muJ591
- [A radioimmunoconjugate of a mouse monoclonal antibody (MoAb) J591 labelled with Iodine 131 (I-131). MoAb muJ591 recognizes the extracellular domain of the prostate specific membrane antigen (PSMA) and reacts with tumor vascular endothelium. Using MoAb muJ591 as a carrier for I-131 results in the targeted imaging and/or destruction of cells overexpressed PSM. ( NCI )] (UMLS (NCI) C0935700) =Amino Acid, Peptide, or Protein; Pharmacologic Substance; Immunologic Factor
| - 44. ionic bond
- [attractive force that draws electrons from one atom to another. ( CSP )] (UMLS (CSP) C0596800) =Natural Phenomenon or Process =chemical bond;
|
- 13. Iodine Povidone Topical
- (UMLS (NCI) C0728772) =Pharmacologic Substance
| - 45. ionic strength
- [measure of the level of electrical force in an electrolytic solution. ( CSP )] (UMLS (NCI) C0086486) =Quantitative Concept =Chemical Properties;
|
- 14. IODIPAMIDE SODIUM
- (UMLS (NCI) C0301445) =Organic Chemical; Indicator, Reagent, or Diagnostic Aid ;
| - 46. ionization
- [Any process by which a neutral atom gains or loses electrons, thus acquiring a net charge, as the dissociation of a substance in solution into ions or ion production by the passage of radioactive particles. ( NCI )] (UMLS (CSP) C0596801) =Phenomenon or Process =chemical reaction;
|
- 15. IODIXANOL
- (UMLS (NCI) C0063757) =Organic Chemical; Indicator, Reagent, or Diagnostic Aid ;
=Triiodobenzoic Acids;
[DX101] NON-IONIC CONTRAST MEDIA =IODIXANOL 270 mgI/ml;
IODIXANOL 320 mgI/ml;
| - 47. ionization constant
- [fixed quantity that is based on the ratio of the ions produced from a given substance to the undissociated molecules of the substance. ( CSP )] (UMLS (CSP) C0596802) =Quantitative Concept =Chemical Properties;
|
- 16. Iodized Oil
- [The mixture contains 38-42% organically combined iodine that is used as a diagnostic aid (radiopaque medium). (From Merck Index, 11th ed) ( MSH )] (UMLS (NCI) C0021972) =Lipid; Indicator, Reagent, or Diagnostic Aid ;
| - 48. ionizing radiation
- [radiation with sufficient quantal energy to cleave covalent bonds in biomolecules, resulting in ion pair products. ( CSP )] (UMLS (CSP) C0034538) =Natural Phenomenon or Process =radiation;
=Gamma Radiation;
Radiation, X-Rays;
high energy particle;
|
- 17. iodo fatty acid
- [ ] (UMLS (CSP) C0598432) =Lipid ;
| - 49. Ionizing Radiation-Related Malignant Neoplasm
- (UMLS (NCI) C1334285) =Neoplastic Process ;
|
- 18. Iodofenphos
- (UMLS (NCI) C0063778) =Organophosphorus Compound; Pharmacologic Substance ;
| - 50. ionomycin
- [a polyether ionophore. ( CSP )] (UMLS (NCI) C0022020) =Lipid; Pharmacologic Substance =Antibiotics;
ionophore |
- 19. Iodothiouracil
- (UMLS (NCI) C0063799) =Nucleic Acid, Nucleoside, or Nucleotide; Pharmacologic Substance ;
| - 51. ionophore
- [molecule that allows ions to cross lipid bilayers; there are two classes: carriers and channels; carriers, like valinomycin, form cage like structures around specific ions, diffusing freely through the hydrophobic regions of the bilayer; channels, like gramicidin, form continuous aqueous pores through the bilayer, allowing ions to diffuse through. ( CSP )] (UMLS (CSP) C0022022) =Pharmacologic Substance ;
=ion transport;
=ionomycin;
monensin;
|
- 20. Iodotope
- (UMLS (NCI) C1328689) =Pharmacologic Substance; Indicator, Reagent, or Diagnostic Aid; Inorganic Chemical
| - 52. iontherapy
- [therapeutic introduction of ions of soluble salts into tissues by means of electric current; a form of electro-osmosis; also, a process of increasing the penetration of drugs into surface tissues by the application of electric current. ( CSP )] (UMLS (CSP) C1537073) iontophoresis therapy;
=Therapeutic or Preventive Procedure ;
=body fluid balance therapy;
|
- 21. iodotyrosine
- [product from the iodination of tyrosine; in the biosynthesis of thyroid hormones, tyrosine is first iodized to monoiodotyrosine. ( CSP )] (UMLS (CSP) C0021996) =Amino Acid, Peptide, or Protein; Biologically Active Substance =tyrosine analog;
| - 53. IontophoresisRoute
- [Iontophoresis ( HL7V3.0 )] (UMLS (HL7) C1700702) =Functional Concept ;
=RouteByMethod;
=Topical application, iontophoresis;
|
- 22. IODOXAMATE MEGLUMINE
- (UMLS (NCI) C0066374) =Organic Chemical; Pharmacologic Substance; Indicator, Reagent, or Diagnostic Aid
| - 54. IOPANOIC ACID
- [Radiopaque medium used as diagnostic aid. ( MSH )] (UMLS (NCI) C0022028) =Organic Chemical; Indicator, Reagent, or Diagnostic Aid =Iodobenzenes;
[DX102] IONIC CONTRAST MEDIA =IOPANOIC ACID 500 MG |
- 23. Iodoxamic Acid
- (UMLS (NCI) C0063803) =Organic Chemical; Pharmacologic Substance ;
| - 55. IOPROMIDE
- [A contrast medium. ( NCI )] (UMLS (NCI) C0063817) =Organic Chemical; Indicator, Reagent, or Diagnostic Aid ;
=IOHEXOL;
[DX101] NON-IONIC CONTRAST MEDIA =IOPROMIDE 240 MG/ML;
IOPROMIDE 150 MG/ML;
IOPROMIDE 300 MG/ML;
IOPROMIDE 370 MG/ML;
|
- 24. Ioglicic Acid
- (UMLS (NCI) C0063806) =Organic Chemical
| - 56. Iosumetic Acid
- (UMLS (NCI) C0605534) =Organic Chemical; Pharmacologic Substance
|
- 25. ioglycamate
- [ ] (UMLS (CSP) C0598550) =Organic Chemical
| - 57. IOTHALAMIC ACID
- [An ionic triiodinated benzoate used as a contrast agent in diagnostic imaging. Like other organic iodine compounds, iothalamic acid blocks x-ray and appears opaque on x-ray film, thereby enhancing the visibility of structure and organs during angiography, arteriography, arthrography, cholangiography and computed tomography (CT) scanning procedures. ( NCI )] (UMLS (NCI) C0022034) =Organic Chemical; Indicator, Reagent, or Diagnostic Aid
|
- 26. IOGLYCAMIC ACID
- [A radiopaque medium. It is a mixture of its meglumine and sodium salts and is used to visualize the biliary tract. ( MSH )] (UMLS (NCI) C0022003) =Organic Chemical; Indicator, Reagent, or Diagnostic Aid
| - 58. IOVERSOL
- (UMLS (NCI) C0063828) =Organic Chemical; Indicator, Reagent, or Diagnostic Aid ;
=Triiodobenzoic Acids;
[DX101] NON-IONIC CONTRAST MEDIA =IOVERSOL 160 MG/ML;
IOVERSOL 240 MG/ML;
IOVERSOL 300 MG/ML;
IOVERSOL 320 MG/ML;
IOVERSOL 350 MG/ML |
- 27. IOHEXOL
- [An effective non-ionic, water-soluble contrast agent which is used in myelography, arthrography, nephroangiography, arteriography, and other radiographic procedures. Its low systemic toxicity is the combined result of low chemotoxicity and low osmolality. ( MSH )] (UMLS (NCI) C0022005) =Organic Chemical; Indicator, Reagent, or Diagnostic Aid =Triiodobenzoic Acids;
[DX101] NON-IONIC CONTRAST MEDIA =IOPROMIDE;
Ioxilan;
IOHEXOL 755 MG/ML;
Iohexol 388 MG/ML;
IOHEXOL 517.7 MG/ML;
Iohexol 647 MG/ML;
IOHEXOL 302 MG/ML;
IOHEXOL 435 MG/ML;
| - 59. Iowa Tribe of Kansas and Nebraska
- (UMLS (HL7) C1554329) =Population Group =NativeEntityContiguous;
|
- 28. Iolidonic Acid
- (UMLS (NCI) C0601034) =Organic Chemical; Pharmacologic Substance ;
| - 60. Iowa Tribe of Oklahoma
- (UMLS (HL7) C1554330) =Population Group =NativeEntityContiguous;
|
- 29. Iomeglamic Acid
- (UMLS (NCI) C0063809) =Organic Chemical; Pharmacologic Substance ;
| - 61. IOXAGLIC ACID
- [A ionic triiodinated benzoate used as a contrast agent in diagnostic imaging. Like other organic iodine compounds, ioxaglic acid blocks x-ray and appears opaque on x-ray film, thereby enhancing the visibility of structure and organs during angiography, arteriography, arthrography, cholangiography, urography and computed tomography (CT) scanning procedures. Ioxaglic acid has low osmolarity and therefore, is associated with few side effects compared to older contrast agents. ( NCI )] (UMLS (NCI) C0022041) =Organic Chemical; Indicator, Reagent, or Diagnostic Aid =Triiodobenzoic Acids;
=IOXAGLATE |
- 30. ion
- [atom or radical having an electrical charge owing to the loss or gain of one or more electrons; substances that form ions are called electrolytes. ( CSP )] (UMLS (CSP) C0022023) =Element, Ion, or Isotope ;
=electrolyte;
Chemical =anion;
cation;
electrolyte;
H+ element;
Chloride;
CALCIUM ION;
carbon ion;
magnesium ion;
polyion;
K+ element;
Na+ element;
F- element;
anion | - 62. Ioxilan
- (UMLS (NCI) C0063829) =Organic Chemical; Pharmacologic Substance ;
=IOHEXOL;
[DX101] NON-IONIC CONTRAST MEDIA =IOXILAN 300 mgI/ml;
IOXILAN 350 mgI/ml;
|
- 31. ION
- [Administration by means of an electric current where ions of soluble salts migrate into the tissues of the body. (FDA) ( NCI )] (UMLS (NCI) C0022024) =Therapeutic or Preventive Procedure ;
| - 63. Ioxitalamic Acid
- (UMLS (NCI) C0063830) =Organic Chemical; Pharmacologic Substance ;
|
- 32. Ion Channel
- [molecule-sized pores in biomembranes that permit the passage of hydrophilic solutes such as inorganic ions, and the proteins that form such pores and control their permeability. ( CSP )] (UMLS (NCI) C0022009) =Amino Acid, Peptide, or Protein; Biologically Active Substance =membrane transport protein;
=calcium channel;
potassium channel;
nicotinic receptor;
sodium channel;
chloride channel;
hydrogen channel;
voltage gated channel;
aquaporin;
| |
home
